Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleCommentary

Data Generated by Quantitative LC-MS Proteomics Are Only the Start and Not the Endpoint: Optimization of QconCAT-Based Measurement of Hepatic UDP-Glucuronosyltransferase Enzymes with Reference to Catalytic Activity

Brahim Achour, Alyssa Dantonio, Mark Niosi, Jonathan J Novak, Zubida M Al-Majdoub, Theunis C Goosen, Amin Rostami-Hodjegan and Jill Barber
Drug Metabolism and Disposition March 26, 2018, dmd.117.079475; DOI: https://doi.org/10.1124/dmd.117.079475
Brahim Achour
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyssa Dantonio
2 Pfizer Inc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Niosi
2 Pfizer Inc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan J Novak
2 Pfizer Inc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zubida M Al-Majdoub
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theunis C Goosen
2 Pfizer Inc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amin Rostami-Hodjegan
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Barber
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jill.barber@manchester.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplemental

    • Supplemental Data -

      Supplemental Methods

      Supplemental Figure 1 - Elution profiles of UGT Q-peptides analyzed in the same LC-MS/MS assay (sample HH06)

      Supplemental Figure 2 - Correlation of UGT abundance values measured using the two QconCAT peptides representing UGT1A1 (A), UGT1A4 (B), UGT1A6 (C), UGT2B4 (D), UGT2B7 (E) and UGT2B15 (F) after optimization

      Supplemental Figure 3 - Cross-laboratory evaluation of UGT abundance measurements using stable isotope-labeled
      (SIL) peptide standards and quantification concatemer (QconCAT) standard: Box and whiskers plot of the abundance
      measurements (n=24) of UGT enzymes quantified by the two methods (A) with the individual values shown in panel
      (B)

      Supplemental Figure 4 - Correlation between individual protein abundance measurements (n=24) of UGTs 1A1 (A), 1A3 (B), 1A4 (C), 1A6 (D), 1A9 (E), 2B4 (F), 2B7 (G) and 2B15 (H) using two proteomic methodologies (SIL vs QconCAT) after optimization of QconCAT data analysis

      Supplemental Figure 5 - Correlation matrix of individual protein abundances of UGT enzymes (abundance vs abundance) using QconCAT methodology (n=24)

      Supplemental Table 1 - Comparison of QconCAT-based UGT measurements before and after optimization of data analysis

      Supplemental Table 2 - Correlation matrix of QconCAT-derived individual UGT enzyme abundances (n=24) with activity rates (abundance vs activity)

      Supplemental Table 3 - Correlation matrix of individual protein abundances of UGT enzymes (abundance vs abundance) using QconCAT methodology (n=24)

      Supplemental Table 4 - Enzymes with established QconCAT-based quantification methods after optimization

      References

Next
Back to top

In this issue

Drug Metabolism and Disposition: 51 (12)
Drug Metabolism and Disposition
Vol. 51, Issue 12
1 Dec 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Data Generated by Quantitative LC-MS Proteomics Are Only the Start and Not the Endpoint: Optimization of QconCAT-Based Measurement of Hepatic UDP-Glucuronosyltransferase Enzymes with Reference to Catalytic Activity
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCommentary

Data Generated by Quantitative LC-MS Proteomics Are Only the Start and Not the Endpoint: Optimization of QconCAT-Based Measurement of Hepatic UDP-Glucuronosyltransferase Enzymes with Reference to Catalytic Activity

Brahim Achour, Alyssa Dantonio, Mark Niosi, Jonathan J Novak, Zubida M Al-Majdoub, Theunis C Goosen, Amin Rostami-Hodjegan and Jill Barber
Drug Metabolism and Disposition March 26, 2018, dmd.117.079475; DOI: https://doi.org/10.1124/dmd.117.079475

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCommentary

Data Generated by Quantitative LC-MS Proteomics Are Only the Start and Not the Endpoint: Optimization of QconCAT-Based Measurement of Hepatic UDP-Glucuronosyltransferase Enzymes with Reference to Catalytic Activity

Brahim Achour, Alyssa Dantonio, Mark Niosi, Jonathan J Novak, Zubida M Al-Majdoub, Theunis C Goosen, Amin Rostami-Hodjegan and Jill Barber
Drug Metabolism and Disposition March 26, 2018, dmd.117.079475; DOI: https://doi.org/10.1124/dmd.117.079475
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Kirchhoff’s Laws and the Well-Stirred Model
  • The Early Days: A Reminiscence
  • kcat Assessment of UGT Enzymes across Different Organs
Show more Commentary

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics